Disc Medicine, Inc. (ticker: IRON) is a clinical-stage biopharmaceutical company focused on discovering and developing treatments for serious hematologic diseases. Its lead product candidate is bitopertin, a GlyT1 inhibitor being evaluated in clinical trials. The company targets rare blood disorders and conducts preclinical and clinical research programs aimed at addressing unmet medical needs in hematology.
expected 2026-12-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073602 | EDGAR | 118K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-028390 | EDGAR | 115K words |
| 2024-03-21 | 2023-12-31 | 0000950170-24-034432 | EDGAR | 126K words |
| 2023-03-31 | 2022-12-31 | 0000950170-23-011139 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0000950170-22-003288 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001213900-21-018272 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-30 | 2026-06-30 | 0001193125-26-325034 | EDGAR | 71K words |
| 2025-11-06 | 2025-09-30 | 0001193125-25-268200 | EDGAR | 72K words |
| 2025-08-07 | 2025-06-30 | 0001816736-25-000007 | EDGAR | 70K words |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065069 | EDGAR | 67K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124650 | EDGAR | 70K words |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093357 | EDGAR | 67K words |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056304 | EDGAR | 63K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061572 | EDGAR | 70K words |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041594 | EDGAR | 69K words |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021963 | EDGAR | 66K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024195 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016671 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-10 | 0001193125-26-387351 | EDGAR | 2K words |
| 2026-07-30 | 0001193125-26-325031 | EDGAR | 2K words |
| 2026-02-27 | 0001193125-26-082855 | EDGAR | 1K words |
| 2026-02-26 | 0001193125-26-073594 | EDGAR | 2K words |
| 2026-02-17 | 0001193125-26-053066 | EDGAR | 2K words |
| 2026-02-13 | 0001193125-26-051504 | EDGAR | 2K words |
| 2026-01-12 | 0001193125-26-009871 | EDGAR | 1K words |
| 2025-12-08 | 0001193125-25-310664 | EDGAR | 4K words |
| 2025-11-06 | 0001193125-25-268196 | EDGAR | 2K words |
| 2025-10-22 | 0001193125-25-245871 | EDGAR | 1K words |
137 total filings indexed. 109 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001816736 |
| Ticker | IRON |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.discmedicine.com |
| Listed | 2021-02-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IRON (~200 tokens, structured JSON with cryptographic provenance)